The following is a summary of “Correlation between hs-CRP-triglyceride glucose index and NAFLD and liver fibrosis,” published in the April 2025 issue of the BMC Gastroenterology by Zhou et al. The novel serum high-sensitivity C-reactive protein-triglyceride glucose index (CTI) has emerged as a composite biomarker that captures both insulin resistance and systemic inflammation—two interrelated mechanisms […]
The post Composite CTI as a Predictive Biomarker for NAFLD and Liver Fibrosis first appeared on Physician’s Weekly.
